124I-hu3F8

humanized anti-GD2 antibody (hu3F8) · Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 124I-hu3F8, covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study [NA]